Publications

December 2022
Article

I Don't 'Recall': The Decision to Delay Innovation Launch to Avoid Costly Product Failure

By: Byungyeon Kim, Oded Koenigsberg and Elie Ofek

Innovations embody novel features or cutting-edge components aimed at delivering desired customer benefits. Oftentimes, however, we observe the need to recall new products shortly after their introduction. Indeed, a firm may rush an innovation to market in an attempt... View Details

Keywords: Innovation Management; Innovation And Strategy; Product Development Strategy; Product Introduction; Quality Control; Product Recalls; Game Theory; Market Timing; Innovation Strategy; Product Launch; Product Development

Find at Harvard

February 2010 (Revised August 2010)
Case

Sheikh Mohammed and the Making of 'Dubai, Inc.'

By: Anthony Mayo, Nitin Nohria, Umaimah Mendhro and Johnathan Cromwell

Sheikh Mohammed bin Rashid Al Maktoum has converted Dubai from a sleepy little coastal village into a world-class city, famous for its ambition, drive, and economic promise. He is the founder, part-owner, and visionary behind companies such as Emirates Airlines, a... View Details

Keywords: Development Economics; Leadership Style; Emerging Markets; Personal Development and Career; Business and Community Relations; Business and Government Relations; Dubai

21 Jul 2021
Research & Ideas

What Does an ESG Score Really Say About a Company?

Receiving more information can clarify the complex, but not when it comes to environmental, social, and governance (ESG) scores. A recent study shows that the more information a company discloses about its ESG practices, the more rating agencies disagree on how well... View Details

Keywords: by Kristen Senz

2008
Working Paper

Extending Producer Responsibility: An Evaluation Framework for Product Take-Back Policies

By: Michael W. Toffel, Antoinette Stein and Katharine Lee

Manufacturers are increasingly being required to adhere to product take-back regulations that require them to manage their products at the end of life. Such regulations seek to internalize products' entire life cycle costs into market prices, with the ultimate... View Details

Keywords: Product; Cost; Corporate Social Responsibility and Impact; Environmental Sustainability

SSRN

Read Now

07 Apr 2020
Research & Ideas

What Customers Need to Hear from You During the COVID Crisis

As the COVID-19 virus pandemic began to sweep across the world, Doug McMillon and his team at Walmart watched in horror. Suddenly, they realized, tomorrow would be nothing like “business as usual” and everything in the company’s marketing... View Details

Keywords: by Jill Avery and Richard Edelman

29 Sep 2009
First Look

First Look: September 29

leverage during bad times. If refinancing-facilitated homeowner-equity extraction is sufficiently widespread—as it was during the years leading up to the peak of the U.S. residential real-estate market—the inadvertent coordination of leverage during a View Details

Keywords: Martha Lagace

10 Aug 2015
Research & Ideas

New Medical Devices Get To Patients Too Slowly

market has grown at a rate of 6 percent annually in the United States. Government approval of new medical devices seems slower than it needs to be, according to a new study. ©iStock.com/basha The FDA has only regulated medical devices... View Details

Keywords: by Michael Blanding; Health; Technology

2024
Article

Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway

By: Mateo Aboy, Cristina Crespo and Ariel Stern

Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States

Read Now

April 2014 (Revised July 2015)
Case

Sanofi Pasteur: The Dengue Vaccine Dilemma

By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud

In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details

Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France

06 Mar 2007
First Look

First Look: March 6, 2007

designed to enhance safety and effectiveness had the unintended effect of changing how men enacted their masculine identities at work. Interview and participant observation data show that the major reorientation was away from seeking to... View Details

Keywords: Martha Lagace

August 2009 (Revised August 2009)
Case

Swire Beverages: Implementing CSR in China

By: Christopher Marquis, G.A. Donovan and YiKwan Chu

Swire Beverage, the largest Coca-Cola bottler in China, recently created a corporate social responsibility (CSR) organization to oversee environmental, community, health and safety initiatives at the companies' nine bottling plants in China. The case considers... View Details

Keywords: Brands and Branding; Corporate Social Responsibility and Impact; Organizational Design; Business and Stakeholder Relations; Partners and Partnerships; Non-Governmental Organizations; Food and Beverage Industry; China

25 Sep 2007
First Look

First Look: September 25, 2007

will in fact homogenize consumption patterns, and a few superstar products will emerge as winners in the market place. In this study, using two large customer transactions data sets obtained from an online music service and an online DVD... View Details

Keywords: Martha Lagace

February 2025
Case

Abiomed: Clinical Trials and Tribulations

By: Satish Tadikonda, Faith Robertson and William Marks

After receiving 510(k) clearance for the Impella 2.5 device, Abiomed had proceeded to conduct a premarket approval (PMA) process as well to prove clinical superiority, earn greater protection, and extend commercial runway. However, in the middle of the clinical trial... View Details

Keywords: Corporate Disclosure; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Launch; Medical Devices and Supplies Industry

November 2001 (Revised March 2002)
Case

Digital Angel

By: Youngme E. Moon and Kerry Herman

Digital Angel is considering the appropriate marketing plan for the launch of its new locator device. The device, a watch and pager worn in combination, provides GPS location information and monitors heart rate and body temperature via body sensors. Parents of young... View Details

Keywords: Information; Safety; Rights; Market Entry and Exit; Ethics; Product Launch; Brands and Branding; Product Development

08 Nov 2010
Research & Ideas

How to Fix a Broken Marketplace

Roth discusses these and other markets in his reflective paper What Have We Learned from Market Design?, which draws from decades of his fieldwork. In the paper, published in 2008 and updated in September... View Details

Keywords: by Carmen Nobel; Health

16 Sep 2015
Research & Ideas

Can Applied Economics Save Homeless Puppies?

matching system for New England, correcting public school choice programs in New York and Boston, and tackling markets for new medical residents, economists, and lawyers. That same year, Christine L. Exley and Elena Battles launched a... View Details

Keywords: by Carmen Nobel; Retail

24 Jan 2024
Op-Ed

Why Boeing’s Problems with the 737 MAX Began More Than 25 Years Ago

Stonecipher that turned Boeing’s culture from excellence in aviation design, quality, and safety into emphasizing short-term profit and distributing cash to shareholders via stock buybacks. McNerney compounded the problem through his... View Details

Keywords: by Bill George; Air Transportation; Transportation; Aerospace

2022
Working Paper

The Need for Speed: The Impact of Capital Constraints on Strategic Misconduct

By: F. Christopher Eaglin

Under what conditions do firms engage in strategic misconduct? Why do they undertake actions that increase profitability yet break laws or violate strong norms often with costly consequences for public welfare? The strategic management literature offers two external... View Details

Keywords: Corporate Misconduct; Capital Constraints; Organizations; Crime and Corruption; Behavior; Situation or Environment; Capital

Read Now

January–February 2023
Article

Data-Driven COVID-19 Vaccine Development for Janssen

By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan

The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details

Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry

Find at Harvard